|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Safety,pharmacodynamics,and pharmacokinetics of single doses of BAY 59-7939,an oral,direct factor Xa inhibitor显示文摘 | Kubitza D Becka M Voith B | | 0，，： | 1 |
| 2 | Safety, pharmaco- dynamics, and pharmacokinetics of single doses of BAY 59-7939 an oral, direct factor X a inhibitor 显示文摘 | Kubitza D Becka M Voith B | 2005 | Clin Pharmacol Ther2005，78，4： | 1 |
| 3 | Safety,pharmacodynamics,and pharmacokinetics of single doses of BAY 59-7939,an oral,direct factor Xa inhibitor显示文摘 | KUBITZA D BECKA M VOITH B | 2005 | Clin Pharmacol Ther2005，78，4： | 1 |
| 4 | Preparation and reactions of 2, 2-dimethyl-1, 3-dioxan-5-one-SAMP-hydrazone : a versatile chiral dihydroxyacetone equivalent 显示文摘 | ENDERS D VOITH M INCE S J | 2002 | Synthesis2002，，12： | 1 |
| 5 | Safety,pharmacodynamics,and pharmacokinetics of single doses of BAY 59-7939,an oral,direct factor Xa inhibitor显示文摘 | Kuhitza D Becka M Voith B | 2005 | Clin Pharmacol Ther2005，78，4： | 1 |
| 6 | Safety, phannacodynam- ies, and pharmacokineties of single doses of BAY 59-7939, an oral, direct factor Xa inhibitor 显示文摘 | Kubitza D Beeka M Voith B | 2005 | Clin Pharmacol Therapeut2005，78，4： | 1 |
| 7 | Safety, pharmacodynam- ics, and pharmacokinetics of single doses of BAY59 - 7939, an oral, direct factor Xa inhibitor 显示文摘 | Kubitza D Becka M Voith B | 2005 | Clin Pharmacol Ther2005，78，4： | 1 |
| 8 | Safety, pharmacodynamics, and pharmacokinetics of single doses of BAY 59-7939, an oral, direct factor Ⅹa inhibitor显示文摘 | KUBITZA D BECKA M VOITH B | 2005 | Clin Pharmacol Ther2005，78，4： | 1 |
| 9 | Safety, pharmacodynamics, and pharmacokinetics of single doses of BAY 59-7939, an oral, direct factor Xa inhibitor显示文摘 | Kubitza D Becka M Voith B | 2005 | Clin Pharmacol Ther2005，78，4： | 1 |
| 10 | Safety,pharmacodynamics,and pharmacokinetics of single doses of BAY 59-7939,an oral,direct factor Ⅹa inhibitor显示文摘 | Kubitza D Becka M Voith B | 2005 | Clin Pharmacol Ther2005，78，4： | 1 |
| 11 | Safety, pharmacody- namics, and pharmacokinetics of single doses of BAY 59-7939,an oral, direct factor X a inhibitor显示文摘 | Kubitza D Becka M Voith B | 2005 | Clin Pharmacol Ther2005，78，： | 1 |
| 12 | Effects of cumulative violence exposure on children's trauma and depression symp- toms: A social ecological examination using fixed effects regres- sion显示文摘 | Voith L A Gromoske A N Holmes M R | 2014 | Journal of Child & Adolescent Trauma2014，7，4： | 1 |
| 13 | Safety, pharmaco- dynamics, and pharmacokinetics of single doses of BAY 59- 7939, an oral, direct factor Xa inhibitor 显示文摘 | KUBITZA D BECKA M VOITH B | 2005 | Clin Pharmacol Ther2005，78，4： | 1 |
| 14 | Safety, pharmacodynamics, and pharmacokinetics of single doses of BAY 59-7939, an oral, direct factor Xa inhibitor显示文摘 | Kubitza B Becka M Voith B | 2005 | Clin Pharmacol Ther2005，78，4： | 1 |
| 15 | Safety,pharmacodynamics,and pharmacokinetics of single doses of BAY 59-7939,an oral,direct factor Xa inhibitor显示文摘 | Kubitza D Becka M Voith B | 2005 | C1in Pharmacol Ther2005，78，4： | 1 |
| 16 | Safety,pharmacodynamics,and pharmacokinetics of single doses of BAY 59-7939,an oral,direct Factor Xa inhibitor显示文摘 | Kuhitza D Becka M Voith B | 2005 | Clin Pharmacol Ther2005，78，4： | 1 |
| 17 | Safety, pharmacodynamics, and pharmacokinetics of single doses of BAY 59-7939 an oral, direct factor Xa inhibitor 显示文摘 | KUBITZA D BECKA M VOITH B | 2005 | Clin Pharmacol Ther2005，78，4： | 1 |
| 18 | Effect of enoxaparin on the safety, tolerability, pharmacodynamics and pharmacokinetics of BAY 59-7939-an oral, direct Factor Xa inhibitor显示文摘 | Kubilza D Becka M Voith B | 2005 | Thromb Haemost2005，3，1： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员